See on Scoop.it – Cardiovascular and vascular imaging
Abiomed disclosed that it gained regulatory approval in China to roll out two crucial models of its Impella heart pump and related technology, capping a quarter where revenue and net income soared.
See on www.fiercemedicaldevices.com
Leave a Reply